646 related articles for article (PubMed ID: 3864527)
21. Topoisomerase II levels during granulocytic maturation in vitro and in vivo.
Kaufmann SH; McLaughlin SJ; Kastan MB; Liu LF; Karp JE; Burke PJ
Cancer Res; 1991 Jul; 51(13):3534-43. PubMed ID: 1647269
[TBL] [Abstract][Full Text] [Related]
22. Distribution of VIM-2 and SSEA-1 glycoconjugate epitopes among human leukocytes and leukemia cells.
Macher BA; Beckstead JH
Leuk Res; 1990; 14(2):119-30. PubMed ID: 1690317
[TBL] [Abstract][Full Text] [Related]
23. Changes in glycosphingolipids accompanying the differentiation of human squamous SQCC/Y1 cells.
Tatsumura T; Ariga T; Yu RK; Sartorelli AC
Cancer Res; 1988 Apr; 48(8):2121-4. PubMed ID: 3258184
[TBL] [Abstract][Full Text] [Related]
24. Neutral and sialosyl glycosphingolipid composition and metabolism of human T-lymphoblastic cell line MOLT-3 cells: distinctive changes as markers specific for their differentiation.
Akashi M; Takaku F; Nojiri H; Miura Y; Nagai Y; Saito M
Blood; 1988 Aug; 72(2):469-79. PubMed ID: 3261182
[TBL] [Abstract][Full Text] [Related]
25. Changes in glycosphingolipid composition during differentiation of human embryonic stem cells to ectodermal or endodermal lineages.
Liang YJ; Yang BC; Chen JM; Lin YH; Huang CL; Cheng YY; Hsu CY; Khoo KH; Shen CN; Yu J
Stem Cells; 2011 Dec; 29(12):1995-2004. PubMed ID: 21956927
[TBL] [Abstract][Full Text] [Related]
26. Glycosphingolipid expression in solid tumours and transformed cell lines.
Berra B; Colombo I; Monteggia E; Montorfano G; Moretti S; Rapelli S; Sottocornola E
Indian J Biochem Biophys; 1997; 34(1-2):170-7. PubMed ID: 9343946
[TBL] [Abstract][Full Text] [Related]
27. Influence of humoral regulators on proliferation and maturation of normal and leukemic cells.
Karp JE; Burke PJ
Cancer Res; 1976 May; 36(5):1674-9. PubMed ID: 1063598
[TBL] [Abstract][Full Text] [Related]
28. Mast cell heterogeneity. Differential synthesis and expression of glycosphingolipids by mouse serosal mast cells as compared to IL-3-dependent bone marrow culture-derived mast cells before or after coculture with 3T3 fibroblasts.
Raizman MB; Austen KF; Katz HR
J Immunol; 1990 Sep; 145(5):1463-8. PubMed ID: 2200824
[TBL] [Abstract][Full Text] [Related]
29. Effect of AML serum on normal human myeloid differentiation and hexamethylene bisacetamide-induced granulocytic differentiation of the human HL-60 promyelocytic leukaemic cell line.
Hassan HT; Rees JK
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(1):151-9. PubMed ID: 1695170
[TBL] [Abstract][Full Text] [Related]
30. The death-associated protein kinase 2 is up-regulated during normal myeloid differentiation and enhances neutrophil maturation in myeloid leukemic cells.
Rizzi M; Tschan MP; Britschgi C; Britschgi A; Hügli B; Grob TJ; Leupin N; Mueller BU; Simon HU; Ziemiecki A; Torbett BE; Fey MF; Tobler A
J Leukoc Biol; 2007 Jun; 81(6):1599-608. PubMed ID: 17347302
[TBL] [Abstract][Full Text] [Related]
31. Differentiation-associated ganglioside changes in chronic myelogenous leukemia cells.
Tsuboyama A; Sakamoto S; Takaku F
Nihon Ketsueki Gakkai Zasshi; 1985 Sep; 48(6):1480-4. PubMed ID: 3867216
[No Abstract] [Full Text] [Related]
32. Monosialogangliosides of human myelogenous leukemia HL60 cells and normal human leukocytes. 2. Characterization of E-selectin binding fractions, and structural requirements for physiological binding to E-selectin.
Stroud MR; Handa K; Salyan ME; Ito K; Levery SB; Hakomori S; Reinhold BB; Reinhold VN
Biochemistry; 1996 Jan; 35(3):770-8. PubMed ID: 8547257
[TBL] [Abstract][Full Text] [Related]
33. Neolacto-series gangliosides induce granulocytic differentiation of human promyelocytic leukemia cell line HL-60.
Nojiri H; Kitagawa S; Nakamura M; Kirito K; Enomoto Y; Saito M
J Biol Chem; 1988 Jun; 263(16):7443-6. PubMed ID: 2836383
[TBL] [Abstract][Full Text] [Related]
34. Identification of a regulatory peptide distinct from normal granulocyte-derived hemoregulatory peptide produced by human promyelocytic HL-60 leukemia cells after differentiation induction with retinoic acid.
Paukovits JB; Paukovits WR; Laerum OD
Cancer Res; 1986 Sep; 46(9):4444-8. PubMed ID: 3460696
[TBL] [Abstract][Full Text] [Related]
35. Chemical, metabolic and immunological characterization of gangliosides of human glioma cells.
Maeda Y; Yamaki T; Yoshikawa J; Tatewaki K; Piao H; Yu H; Ibayashi Y; Hashi K
Cancer Biochem Biophys; 1998 Nov; 16(4):313-32. PubMed ID: 9925280
[TBL] [Abstract][Full Text] [Related]
36. Comparison of glycolipids in various human leukemia cells.
Kyogashima M; Uemura K; Taketomi T
Jpn J Cancer Res; 1987 Nov; 78(11):1229-37. PubMed ID: 3121559
[TBL] [Abstract][Full Text] [Related]
37. Structure-activity relationships for the induction of differentiation of HL-60 human acute promyelocytic leukemia cells by anthracyclines.
Schwartz EL; Sartorelli AC
Cancer Res; 1982 Jul; 42(7):2651-5. PubMed ID: 6952957
[TBL] [Abstract][Full Text] [Related]
38. Changes in topoisomerase I levels and localization during myeloid maturation in vitro and in vivo.
Kaufmann SH; Charron M; Burke PJ; Karp JE
Cancer Res; 1995 Mar; 55(6):1255-60. PubMed ID: 7882318
[TBL] [Abstract][Full Text] [Related]
39. Cell surface membrane protein changes during the differentiation of cultured human promyelocytic leukemia HL-60 cells.
Felsted RL; Gupta SK; Glover CJ; Fischkoff SA; Gallagher RE
Cancer Res; 1983 Jun; 43(6):2754-61. PubMed ID: 6573952
[TBL] [Abstract][Full Text] [Related]
40. New facts and speculations on human myeloid leukemias.
Breitman TR; Gallo RC
Blood Cells; 1981; 7(1):79-89. PubMed ID: 6964818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
